News
News Center
2020-11-05
Join the stroke patient support group and stay updated on stem cell clinical trials!
In February 2020, Jiuzhitang Maker’s clinical trial for a new stem-cell drug received approval—marking the first clinical trial to utilize imported stem cells, the first to target a major neurological indication with stem-cell therapy, and also the first trial approved under the National Medical Products Administration’s resumption of accepting applications for stem-cell clinical trials, specifically one employing bone marrow-derived mesenchymal stem cells. To foster a friendly platform for meaningful exchange, we’ve established a dedicated online community for stroke patients, providing a space where participants can stay updated on stem-cell clinical trial developments, share their medical experiences, and learn from each other’s insights.
+
2020-10-29
What do you know about male menopause?
Research shows that MSCs cultured under normoxic conditions also exhibit some anti-inflammatory regulatory capacity, while itMSCs obtained through hypoxic culture demonstrate even stronger anti-inflammatory abilities. As a result, these hypoxically cultured cells are better equipped to play a crucial role in combating age-related frailty—and hold greater potential to safeguard human health.
+
2020-10-26
In the national quality benchmark selection event organized by China's Ministry of Industry and Information Technology and the China Association for Quality, Jiuzhitang was awarded the title of "2020 National Quality Benchmark."
+
2020-10-23
Patient good news! Stem cell therapy is safe and effective for treating osteoarthritis!
Extensive clinical research data, both domestically and internationally, has confirmed that stem cell therapy is safe and effective in treating knee osteoarthritis. Stem cell therapy significantly improves joint pain symptoms and functional impairments in patients with knee osteoarthritis, while also demonstrating promising long-term benefits, making it a treatment approach with vast potential. For the growing number of arthritis patients, stem cell therapy offers new hope for recovery. We look forward to even more robust research and groundbreaking advancements in cellular treatment technologies!
+
2020-10-23
Support Shenzhen in becoming a global hub for biomedical innovation and development, with a focus on advancing high-performance medical devices, bioinformatics, and cell & gene therapies. Organize and implement specialized initiatives in areas such as precision medicine, stem cells, innovative drug discovery, cutting-edge medical equipment, and critical technologies and equipment for traditional Chinese medicine—strengthening the capabilities of pharmaceutical manufacturing, as well as medical instruments and device production.
+
2020-09-29
Is stem cell therapy effective for heart disease? The evidence is right here.
Today is World Heart Day—let’s join forces to learn about the latest advancements in stem cell research for treating heart disease!
+
2020-09-25
Big news! The Beijing Institute of Stem Cell and Regenerative Medicine has been established in Beijing. The institute is a new R&D institution jointly built by the Beijing Municipal Government and the Chinese Academy of Sciences.
+
2020-09-22
Breaking news! Policies related to stem cell and immune cell medical technologies in Beijing and Anhui Free Trade Zones have been officially released!
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy